Among those candidates, we adopted FISH assay for screening FGFR2 rearrangements in this prospective study, because the majority of our cases were expected not to have archival surgical tissue and it is frequently difficult to obtain enough volume of tumor tissue for many tests including next-generation sequencing (NGS). Here, FGFR2 is linked to neoplasm.